Browse the corpus

REFERENCES DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, "Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents," Februray 12, 2013. Available at file://www.aidsinfo.nih.gov DHHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection," November 5, 2012. Available at file://aidsinfo.nih.gov Hetherington S, Hughes AR, Mosteller M, et al, "Genetic Variations in HLA-B Region and Hypersensitivity Reactions to Abacavir," Lancet , 2002, 359(9312):1121-2. [PubMed 11943262 ] Lucas A, Nolan D, and Mallal S, "HLA-B*5701 Screening for Susceptibility to Abacavir Hypersensitivity," J Antimicrob Chemother , 2007, 59(4):591-3. [PubMed 17317695 ] Mallal S, Nolan D, Witt C, et al, "Association Between Presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and Hypersensitivity to HIV-1 Reverse-Transcriptase Inhibitor Abacavir," Lancet , 2002, 359(9308):727-32. [PubMed 11888582 ] Peyriére H, Nicolas J, Siffert M, et al, “Hypersensitivity Related to Abacavir in Two Members of a Family,” Ann Pharmacother , 2001, 35(10):1291-2. Saez-Llorens X, Nelson RP, Emmanuel P, et al, "A Randomized, Double-Blind Study of Triple Nucleoside Therapy of Abacavir, Lamivudine, and Zidovudine Versus Lamivudine and Zidovudine in Previously Treated Human Immunodeficiency Virus Type 1-Infected Children," Pediatrics , 2001, 107(1). Available at file://www.pediatrics.org/cgi/content/full/107/1/e4 [PubMed 11134468 ] Topic 13185 Version 35.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0505-88.81.100.162-2094B74F85-S244013.14]